Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • New BHM® Anti-Viral Nasal Spray launches in Singapore

    May 17, 2022, 15:42 PM by
    Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, today announces the Singapore launch of its latest technology, BHM® Anti-Viral Nasal Spray, an easy-to-use nasal device with a unique patented formulation, Norizite™, designed to help prevent infection from the inhalation of airborne viruses within the nasal passages. The product will be available in Singapore from 1st May.
    Full story
  • AARDEX® Group adds etectRx to their MEMS® Adherence Hardware ecosystem

    May 17, 2022, 15:42 PM by
    AARDEX® Group adds etectRx to their MEMS® Adherence Hardware ecosystem The partnership sees the integration of AARDEX’s adherence analytics software with etectRx’s ingestible adherence sensor Liege, Belgium (APRIL 28th, 2022) – Belgium-based AARDEX® Group, the leader in measuring and managing medication adherence in clinical trials today announced a strategic partnership with etectRx, Inc. This new collaboration combines etectRx’s ingestible event marker, the ID-Cap™ System, and AARDEX® Group’s MEMS® Adherence Software (MEMS AS®) to track medication-taking behaviors. Together, they provide a holistic, objective, and precise method to measure and manage adherence to solid form dose medications.
    Full story
  • Royal seal of approval for Wales-based resin manufacturer Purolite

    May 17, 2022, 15:42 PM by
    Purolite, an Ecolab company and leading manufacturer of synthetic and agarose-based resins used in the bioprocessing industry, has been awarded the prestigious Queen’s Award for Enterprise in the International Trade category.
    Full story
  • CD Formulation Enriches Its Supply of Active Pharmaceutical Ingredient Excipients

    May 17, 2022, 15:42 PM by
    Continuing to be a trust-worthy CRO company for drug formulation and development, CD Formulation recently announces the enrichment of its active pharmaceutical ingredient excipient offerings. Now a number of API excipients are readily obtainable at CD Formulation, including Cetrorelix Acetate, Fondaparinux Sodium, Calcitriol, Vitamine D3, Tirofiban Hydrochloride, Eptifibatide, Ferric Ammonium Citrate, Calcipotriol API, Calcium Orotate, Meglumine, Obeticholic Acid, Potassium Magnesium Citrate and Magnesium Oxide.
    Full story
  • Adsorptive Polymers Are Now Available at Alfa Chemistry for Applications in Water Treatment, Medicine, Health Care, and Machine Processing

    May 17, 2022, 15:42 PM by
    Full story
  • Alfa Chemistry Launches Heat Stabilizers for PVC Industry

    May 17, 2022, 15:42 PM by
    Full story
  • Biopharma PEG Develops PEG Derivatives for ADCs Development

    May 17, 2022, 15:42 PM by
    Biopharma PEG leapts at the opportunity to develop various high purity PEG derivatives used as ADC linkers.
    Full story
  • 1upHealth Unveils Data Conversion App.

    May 17, 2022, 15:42 PM by
    Good afternoon, all -- 1upHealth, an intelligent health data platform with over 10,000 clinical and payer endpoints, today unveiled SQL on FHIR to streamline access to and make FHIR healthcare data computable to help organizations discover analytical insights and create compelling visualizations. SQL on FHIR allows healthcare organizations to convert FHIR data into a form that is easily searchable for specifics such as a patient’s observations, vital signs, and smoking status. This new platform is the next phase of 1upHealth’s mission to solve healthcare’s biggest data challenges, including helping organizations convert legacy claims and clinical data into clean, uniform FHIR. If interested in learning more about SQL on FHIR, I am happy to connect you with FHIR expert Joe Gagnon, CEO of 1upHealth, and/or a health plan executive to discuss the following: • Why SQL on FHIR fills the market gap for data conversion and will further aid healthcare organizations to perform at their highest levels • Strategies for organizations to enable FHIR analytics to reduce cost and improve operating models, quality metrics, and outcomes • The urgency to convert FHIR into searchable metrics with interoperability regulations looming and how this will help organizations further track and improve population health and SDoH The full release is included above. Please let me know if you have any questions or requests. Thanks! Anisa
    Full story
  • Samsung Biologics Reports First Quarter 2022 Financial Results

    May 17, 2022, 15:42 PM by
    Full story
  • CD ComputaBio Unveils Protein Structure Modeling Service for Drug Development

    May 17, 2022, 15:42 PM by
    Full story
  • Untargeted Lipidomics Now Available with Creative Proteomics’s New Cutting-Edge Lipidomics Platform

    May 17, 2022, 15:42 PM by
    Full story
  • Pronalyse Unveils Gene Therapy Products Characterization Service to Safely Accelerate Drug Development

    May 17, 2022, 15:42 PM by
    Full story
  • Creative Proteomics Metabolomics Expands Service Offering with the Launch of Plant Untargeted Metabolomics Service

    May 17, 2022, 15:42 PM by
    Full story
  • Global Biologics CDMO Market is set to witness a CAGR of 15% to reach $35 billion by 2025, driven by the growing biopharmaceutical end market

    May 17, 2022, 15:42 PM by
    Rapidly expanding pipelines of cell & gene therapies and new vaccines and significant VC fundings are driving the growth of the Biologics CDMO market.
    Full story
  • Biofourmis Receives Significant Growth Investment from General Atlantic to Propel Company to Unicorn Status

    May 17, 2022, 15:42 PM by
    With this investment, Biofourmis plans to scale up its virtual care offerings. This includes delivering personalized and predictive in-home care to a growing number of acutely ill patients and expanding its recently announced virtual specialty care services, Biofourmis Care, to those patients with complex chronic conditions. In parallel, Biofourmis plans to fund clinical trials to advance the development of digital therapies that work in conjunction with high-value drugs to improve efficacy, while forming strategic partnerships with companies in the digital health and virtual-first care ecosystems.
    Full story
  • Onyx Scientific opens second site and expands small molecule CMC services

    May 17, 2022, 15:42 PM by
    Full story
  • WCG Selected as the Institutional Review Board of Record for The Michael J. Fox Foundation’s Parkinson’s Progression Markers Initiative

    May 17, 2022, 15:42 PM by
    PPMI is designed to identify biological markers and clinical changes associated with Parkinson’s disease risk, onset, and progression.
    Full story
  • CTL Amedica Corp. Awarded U.S. Patent for KLIMT™ Expandable Lumbar Interbody Fusion Cage Design

    May 17, 2022, 15:42 PM by
    The US Patent and Trademark Office has awarded CTL Amedica Corporation US PAT 11, 291.559, an official patent for the KLIMT™ Expandable Lumbar Interbody Fusion Cage design. The KLIMT™ features proprietary, 3D-printed, expandable technology.
    Full story
  • New Genedata Screener 19.0 Further Accelerates Biotherapeutics R&D

    May 17, 2022, 15:42 PM by
    The latest version of Genedata Screener features smart workflow automation and fit-for-purpose, big data visualizations that enable fast, functional characterization of tens of thousands of candidate molecules.
    Full story
  • MicrobioSeq Introduces Fungal Whole-Genome De Novo Sequencing Platform to Facilitate Microbial Research

    May 17, 2022, 15:42 PM by
    Full story
  • «
  • 141
  • 142
  • 143
  • 144 (current)
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy